+ General Considerations
- Renal cystadenocarcinoma is an autosomal dominant condition in GSD with a genetic linkage to chromosome 5
- Renal cystadenocarcinoma represent 6% of all renal tumors in GSD
- Renal cystadenocarcinoma has also been described in a GSD-cross dog and Golden Retriever
- Renal cystadenocarcinoma is a bilateral disease with slowly progressive deterioration of renal function
- Renal cystadenocarcinoma is associated with nodular dermatofibrosis and uterine leiomyoma
- Nodular dermatofibrosis is present in all cases and appear as small, firm, and mobile subcutaneous masses
+ Biologic Behavior
- Clinical signs are worse with bilateral disease and the size of skin and uterine tumors increase with advancing age
- Metastasis reported in up to 47% of cases:
- Metastatic sites including sternal and abdominal lymph nodes, liver, lungs, pleura, and peritoneum
- Metastasis is more common with large, solid, and poorly differentiated tumors
- Main causes of death are renal failure, metastatic disease and secondary skin infections
DIAGNOSIS
+ Clinical Signs
- Clinical signs are non-specific such as abdominal enlargement and abdominal pain
- Urinary signs are uncommon
- Skin lesions (i.e., dermatofibrosis) are associated with renal cystadenocarcinomas in GSD
- Lameness caused by either skeletal metastases or hypertrophic osteopathy
+ Urinalysis and Urine Sediment Cytology
- Proteinuria is a common finding with renal tumors
- Hematuria is uncommon
- Urine sediment cytology is rarely diagnostic for renal tumors
+ Blood Tests
- Hematology and serum biochemistry findings are usually normal or non-specific
- Mild-to-moderate normochromic, normocytic anemia can be caused by either hematuria or bone marrow suppression secondary to chronic disease
- Polycythemia is a reported paraneoplastic syndrome with renal tumors
- Uremia may result from obstruction of urinary outflow, bilateral renal tumors, or age-related renal failure
Imaging
+ General Considerations
Survey abdominal and thoracic radiographs, contrast radiography, ultrasonography, CT, and MRI are imaging modalities used to identify the presence and extent of renal tumors
+ Survey Abdominal Radiography
- Survey abdominal radiographic findings: sublumbar lymph node enlargement, renomegaly, and skeletal metastases, especially lumbar vertebrae and pelvis
- Abdominal mass is identified in 81% and localized to the kidney in 54% of dogs with primary renal tumors
- Focal mineralization can be observed but difficult to differentiate tumor from renal calculi and GI opacities
+ Excretory Urography
- Excretory urographic findings: space occupying renal mass, variable opacification of the renal parenchyma, and distortion of the renal pelvis
- Excretory urography successfully identifies a renal mass in 96% dogs with primary renal tumors
+ Ultrasonography
- Ultrasonography results in earlier diagnosis and more successful treatment of renal neoplasia in humans
- Renal tumors, except for LSA, produce a mixed echogenicity with disruption of the normal renal architecture
- Renal LSA is usually hypoechoic
- Ultrasonography is also useful in detecting neoplastic involvement of regional lymph nodes and adjacent structures such as the adrenal glands ± caudal vena cava
+ Advanced Imaging
- CT scans are used for the diagnosis and local staging of renal neoplasia with a high correlation between CT findings and gross pathology
- MRI is preferred for identifying adjacent vascular and visceral invasion, especially if renal-sparing surgery is planned
- Other imaging techniques include caval venography and nuclear scintigraphy
+ Biopsy
- Biopsy is required for definitive diagnosis of renal tumors
- Biopsy techniques: FNA, needle biopsy, and wedge biopsy
- FNA and needle-core biopsy can be performed using a blind, ultrasound-guided, laparoscopic, or open technique
- Ultrasound-guided biopsy is a rapid, safe, and accurate technique for diagnosing focal and diffuse renal disease
- Blind percutaneous needle biopsy can be performed in cats where the kidney can be immobilized by palpation
- Percutaneous biopsy should be performed with bilateral renal lesions or suspected renal LSA
- Single procedure surgical biopsy, staging, and definitive treatment preferred for unilateral lesions
- Complications of needle biopsy: minor localized hemorrhage, microscopic hematuria, and tumor seeding
Treatment
+ Surgery
- Surgical management depends on behaviour of the tumor, presence of metastases and bilateral renal involvement, and invasion of the caudal vena cava and adjacent structures
- Nephroureterectomy is recommended for:
- Malignant renal and ureteral tumors except LSA
- Grading and staging of nephroblastoma
- Nephron sparing techniques should be used for benign tumors and bilateral disease to reduce the risk of renal failure
RENAL CYSTADENOCARCINOMA
T0 | No evidence of neoplasia |
T1 | Small tumor without deformation of the kidney - Primary Tumor |
T2 | Single tumor with deformation ± enlargement of the kidney |
T3 | Tumor invading perinephric structures ± pelvis or ureter ± renal blood vessels |
T4 | Tumor invading adjacent organs |
N0 | No evidence of regional lymph node involvement |
N1 | Ipsilateral regional lymph node involvement - Node |
N2 | Bilateral regional lymph node involvement - Node |
N3 | Distant lymph node involvement |
M0 | No evidence of metastasis |
M1 | Evidence of distant metastasis with site specified with (a) single metastasis, (b) multiple metastasis in 1 organ, and (c) multiple metastasis in ≥ 2 organs - Metastasis |